This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Wyeth Holdings Corporation, De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 113 
1 out of 3 Years Active: 2006-2007
Title: Ian Nicholas Clarke: Innovator in Meningococcal Vaccine Development
Introduction
Ian Nicholas Clarke is a notable inventor based in Southampton, GB. He has made significant contributions to the field of immunology, particularly in the development of vaccines against meningococcal disease. With a total of 2 patents to his name, Clarke's work has the potential to impact public health positively.
Latest Patents
Clarke's latest patents include the "Recombinant microorganism expressing meningococcal class 1 outer membrane protein" and the "Meningococcal class 1 outer-membrane protein vaccine." Both patents focus on the use of outer-membrane vesicles and Class 1 outer membrane proteins to create effective immunization strategies against meningococcal disease. These innovations highlight his commitment to advancing vaccine technology.
Career Highlights
Throughout his career, Ian Nicholas Clarke has worked with prominent organizations, including Wyeth Holdings Corporation and the Dutch Ministry of Health, Welfare and Sport. His experience in these institutions has allowed him to develop and refine his expertise in vaccine research and development.
Collaborations
Clarke has collaborated with esteemed colleagues such as Robert C Seid, Jr. and Peter R Paradiso. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ian Nicholas Clarke's work in the field of meningococcal vaccine development showcases his innovative spirit and dedication to improving public health. His contributions through patents and collaborations are a testament to his impact in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile